terfenadine has been researched along with Chronic Disease in 49 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "H1-antihistamines are the first-line treatment of chronic idiopathic urticaria (CIU), but CIU is occasionally refractory to the conventional treatment doses." | 9.17 | Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations. ( Kabashima, K; Miyachi, Y; Nakahigashi, K; Tanizaki, H, 2013) |
| "The present study examined the impact of once-daily fexofenadine hydrochloride (HCl) 180 mg on health-related quality of life (HRQL) in subjects with chronic idiopathic urticaria (CIU)." | 9.12 | The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. ( Harding, G; Leahy, MJ; Meeves, S; Shikiar, R; Spector, SL, 2007) |
| "This dose-finding study assessed the safety and efficacy of fexofenadine in chronic idiopathic urticaria." | 9.09 | Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. ( Mason, J; Nelson, HS; Reynolds, R, 2000) |
| "The effect of 60 mg twice-daily fexofenadine HCl on health-related quality of life and productivity at work, in the classroom, and during daily activities in patients with moderate to severe chronic idiopathic urticaria symptoms was studied in two identical, 4-week, placebo-controlled, multicenter clinical trials." | 9.09 | Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. ( Finn, AF; Schoenwetter, WF; Thompson, AK, 2000) |
| "In this 4-week, multicenter, placebo-controlled study, 439 patients with moderate to severe pruritus and urticaria received 1 of 4 oral doses of fexofenadine HCl (20, 60, 120, or 240 mg twice a day) or placebo." | 9.09 | A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. ( Finn, AF; Fretwell, R; Kaplan, AP; Long, J; Qu, R, 1999) |
| "Ebastine is a new second generation histamine H1 receptor antagonist that has shown clinical efficacy in the treatment of seasonal and perennial allergic rhinitis and chronic urticaria after once-daily administration." | 9.08 | Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. ( Kalis, B, 1996) |
| "Clinical trials of a new histamine H1-blocker of the III generation zyrtec (cetirizine) manufactured in Belgium (UCB) demonstrated its high efficacy in pollenosis and chronic idiopathic urticaria." | 9.07 | [The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis]. ( Androsov, VN; Belostotskaia, OI; Il'ina, NI, 1994) |
| "Our randomised study in parallel groups, double-blind double placebo, has compared the efficacy, onset of action and safety of terfenadine and cetirizine in chronic idiopathic urticaria." | 9.07 | [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria]. ( Bloom, M; Danglas, P; Hantzperg, M; Lambert, D, 1993) |
| "In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria." | 9.07 | A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. ( Andri, G; Andri, L; Betteli, C; Givanni, S; Lombardi, C; Mezzelani, P; Senna, GE, 1993) |
| "Forty patients with chronic urticaria were treated with terfenadine or astemizole in a randomized double-blind study." | 9.06 | Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients. ( Bödeker, RH; Paul, E, 1989) |
| "Results of a double-blind, randomized, placebo-controlled, parallel study in 37 patients indicate that terfenadine, 60 mg bid, is significantly more effective than placebo and as effective as hydroxyzine, 25 mg qid, in the treatment of chronic idiopathic urticaria without causing the somnolence that was associated with the use of hydroxyzine." | 9.06 | Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. ( Ball, R; Boggs, PB; Ellis, CN; Grossman, J; Gupta, AK; Shulan, D; Washburne, WF, 1989) |
| "The objective of these three double-blind multi-centre studies was to determine whether terfenadine 120 mg once daily has similar efficacy and tolerability as the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 9.06 | Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily. ( , 1989) |
| "The objective of this double-blind study, which is part of a multicenter study, was to determine whether terfenadine (120 mg once daily) has similar efficacy and tolerability to the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 9.06 | Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria. ( Köhler, ME; Paul, E; Reinel, D; Ulrich, R, 1989) |
| "Patients (n = 56) with a diagnosis of chronic idiopathic urticaria were assessed in a fully randomized, double-blind, crossover study to investigate the efficacy of acrivastine at two doses (8 and 4 mg) versus 60 mg terfenadine and placebo administered three times daily." | 9.06 | A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. ( Blog, FB; den Boer, MS; Gibson, JR; Harvey, SG; Jansen, FC; Kuneman, JJ; Starink, TM; van Joost, T; Westerhof, W, 1989) |
| "The efficacy of terfenadine, a nonsedating H1 antihistamine, in the management of chronic idiopathic urticaria was compared with chlorpheniramine and placebo in a parallel multicenter trial." | 9.06 | Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. ( Bernstein, DI; Buckley, CE; Chu, T; Fox, RW; Grant, JA; Rocklin, RE; Schoenwetter, WF; Spector, SL; Stafford, CT; Stroh, JE, 1988) |
| "The use of the nonsedating antihistamine terfenadine (60 mg twice daily) in the treatment of chronic idiopathic urticaria and contact urticaria associated with atopic dermatitis was assessed." | 9.06 | Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis. ( Hjorth, N, 1988) |
| "Two new non-sedating antihistamines, astemizole (10 mg per day) and terfenadine (120 mg per day), were compared in a double-blind randomized study in 42 adult patients suffering from chronic urticaria." | 9.06 | Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. ( Cainelli, T; Mosca, M; Seidenari, S; Valsecchi, R, 1986) |
| "45 patients with chronic urticaria were randomized to double blind therapy with terfenadine an H1-antihistamine or ranitidine, an H2-antihistamine, or a combination of both drugs." | 9.06 | Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. ( Bödeker, RH; Paul, E, 1986) |
| "40 patients suffering from chronic urticaria were randomly treated with either Terfenadine or Astemizole." | 9.05 | [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients]. ( Bödeker, RH; Paul, E, 1985) |
| "Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial." | 9.05 | Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study. ( Ferguson, J; Kenicer, KJ; MacDonald, KJ, 1985) |
| "fexofenadine is clinically effective in the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria for which it is a suitable option for first-line therapy." | 7.70 | Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. ( Jarvis, B; Simpson, K, 2000) |
| "To evaluate the efficacy and safety of once-daily dosing of fexofenadine hydrochloride, 180 mg, on CIU." | 6.71 | Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. ( Georges, G; Kaplan, AP; Liao, Y; Meeves, S; Spector, SL; Varghese, ST, 2005) |
| "Fexofenadine 180 mg is a new antihistamine that is effective in the treatment of chronic urticaria and that has a profile of side effects similar to placebo." | 6.70 | [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients]. ( Bircher, A; Degonda, M; Helbling, A; Pichler, WJ, 2002) |
| " Adverse events occurred in 20 cases (18." | 6.70 | Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria. ( Aunhachoke, K; Charuwichitratana, S; Gherunpong, N; Gritiyarangsan, P; Janjumratsang, P; Jiamton, S; Korkij, W; Krisadapong, J; Kullavanijaya, P; Kulthanan, K; Kuntiranont, M; Sitakalin, C, 2001) |
| "Loratadine is a new selective peripheral histamine H1-receptor antagonist, that is orally effective, long-acting, and devoid of significant central and autonomic nervous system activity." | 6.67 | Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. ( Belaich, S; Bruttmann, G; DeGreef, H; Lachapelle, JM; Paul, E; Pedrali, P; Tennstedt, D, 1990) |
| "Total 100 patients of chronic idiopathic urticaria aged 18 years and above with exclusion and inclusion criteria were selected." | 5.56 | Efficacy of Fexofenadine in the Treatment of Chronic Idiopathic Urticaria. ( Akhter, F; Jahan, H; Nandi, AK, 2020) |
| "H1-antihistamines are the first-line treatment of chronic idiopathic urticaria (CIU), but CIU is occasionally refractory to the conventional treatment doses." | 5.17 | Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations. ( Kabashima, K; Miyachi, Y; Nakahigashi, K; Tanizaki, H, 2013) |
| "The present study examined the impact of once-daily fexofenadine hydrochloride (HCl) 180 mg on health-related quality of life (HRQL) in subjects with chronic idiopathic urticaria (CIU)." | 5.12 | The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. ( Harding, G; Leahy, MJ; Meeves, S; Shikiar, R; Spector, SL, 2007) |
| "In this 4-week, multicenter, placebo-controlled study, 439 patients with moderate to severe pruritus and urticaria received 1 of 4 oral doses of fexofenadine HCl (20, 60, 120, or 240 mg twice a day) or placebo." | 5.09 | A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. ( Finn, AF; Fretwell, R; Kaplan, AP; Long, J; Qu, R, 1999) |
| "This dose-finding study assessed the safety and efficacy of fexofenadine in chronic idiopathic urticaria." | 5.09 | Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. ( Mason, J; Nelson, HS; Reynolds, R, 2000) |
| "The effect of 60 mg twice-daily fexofenadine HCl on health-related quality of life and productivity at work, in the classroom, and during daily activities in patients with moderate to severe chronic idiopathic urticaria symptoms was studied in two identical, 4-week, placebo-controlled, multicenter clinical trials." | 5.09 | Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. ( Finn, AF; Schoenwetter, WF; Thompson, AK, 2000) |
| "Ebastine is a new second generation histamine H1 receptor antagonist that has shown clinical efficacy in the treatment of seasonal and perennial allergic rhinitis and chronic urticaria after once-daily administration." | 5.08 | Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. ( Kalis, B, 1996) |
| "Our randomised study in parallel groups, double-blind double placebo, has compared the efficacy, onset of action and safety of terfenadine and cetirizine in chronic idiopathic urticaria." | 5.07 | [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria]. ( Bloom, M; Danglas, P; Hantzperg, M; Lambert, D, 1993) |
| "Clinical trials of a new histamine H1-blocker of the III generation zyrtec (cetirizine) manufactured in Belgium (UCB) demonstrated its high efficacy in pollenosis and chronic idiopathic urticaria." | 5.07 | [The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis]. ( Androsov, VN; Belostotskaia, OI; Il'ina, NI, 1994) |
| "In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria." | 5.07 | A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. ( Andri, G; Andri, L; Betteli, C; Givanni, S; Lombardi, C; Mezzelani, P; Senna, GE, 1993) |
| "Ten patients with stable chronic asthma completed a randomized double-blind placebo controlled crossover study examining the effect of 120mg terfenadine twice daily for 4 weeks on bronchial responsiveness." | 5.07 | Lack of effect of 4 weeks of oral H1 antagonist on bronchial responsiveness. ( Latimer, KM; Ruffin, RE, 1991) |
| "Forty patients with chronic urticaria were treated with terfenadine or astemizole in a randomized double-blind study." | 5.06 | Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients. ( Bödeker, RH; Paul, E, 1989) |
| "Patients (n = 56) with a diagnosis of chronic idiopathic urticaria were assessed in a fully randomized, double-blind, crossover study to investigate the efficacy of acrivastine at two doses (8 and 4 mg) versus 60 mg terfenadine and placebo administered three times daily." | 5.06 | A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. ( Blog, FB; den Boer, MS; Gibson, JR; Harvey, SG; Jansen, FC; Kuneman, JJ; Starink, TM; van Joost, T; Westerhof, W, 1989) |
| "The objective of this double-blind study, which is part of a multicenter study, was to determine whether terfenadine (120 mg once daily) has similar efficacy and tolerability to the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 5.06 | Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria. ( Köhler, ME; Paul, E; Reinel, D; Ulrich, R, 1989) |
| "The objective of these three double-blind multi-centre studies was to determine whether terfenadine 120 mg once daily has similar efficacy and tolerability as the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 5.06 | Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily. ( , 1989) |
| "Results of a double-blind, randomized, placebo-controlled, parallel study in 37 patients indicate that terfenadine, 60 mg bid, is significantly more effective than placebo and as effective as hydroxyzine, 25 mg qid, in the treatment of chronic idiopathic urticaria without causing the somnolence that was associated with the use of hydroxyzine." | 5.06 | Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. ( Ball, R; Boggs, PB; Ellis, CN; Grossman, J; Gupta, AK; Shulan, D; Washburne, WF, 1989) |
| "45 patients with chronic urticaria were randomized to double blind therapy with terfenadine an H1-antihistamine or ranitidine, an H2-antihistamine, or a combination of both drugs." | 5.06 | Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. ( Bödeker, RH; Paul, E, 1986) |
| "The use of the nonsedating antihistamine terfenadine (60 mg twice daily) in the treatment of chronic idiopathic urticaria and contact urticaria associated with atopic dermatitis was assessed." | 5.06 | Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis. ( Hjorth, N, 1988) |
| "The efficacy of terfenadine, a nonsedating H1 antihistamine, in the management of chronic idiopathic urticaria was compared with chlorpheniramine and placebo in a parallel multicenter trial." | 5.06 | Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. ( Bernstein, DI; Buckley, CE; Chu, T; Fox, RW; Grant, JA; Rocklin, RE; Schoenwetter, WF; Spector, SL; Stafford, CT; Stroh, JE, 1988) |
| "Two new non-sedating antihistamines, astemizole (10 mg per day) and terfenadine (120 mg per day), were compared in a double-blind randomized study in 42 adult patients suffering from chronic urticaria." | 5.06 | Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. ( Cainelli, T; Mosca, M; Seidenari, S; Valsecchi, R, 1986) |
| "Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial." | 5.05 | Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study. ( Ferguson, J; Kenicer, KJ; MacDonald, KJ, 1985) |
| "40 patients suffering from chronic urticaria were randomly treated with either Terfenadine or Astemizole." | 5.05 | [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients]. ( Bödeker, RH; Paul, E, 1985) |
| "It has been difficult to experimentally reproduce synergistic effects of ketoconazole on terfenadine-induced torsade de pointes." | 3.96 | Utilization of the chronic atrioventricular block cynomolgus monkey as an in vivo model to evaluate drug interaction-associated torsade de pointes. ( Chiba, K; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Kambayashi, R; Matsumoto, A; Nunoi, Y; Sakamoto, K; Sugiyama, A, 2020) |
| "fexofenadine is clinically effective in the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria for which it is a suitable option for first-line therapy." | 3.70 | Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. ( Jarvis, B; Simpson, K, 2000) |
| "To evaluate the efficacy and safety of once-daily dosing of fexofenadine hydrochloride, 180 mg, on CIU." | 2.71 | Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. ( Georges, G; Kaplan, AP; Liao, Y; Meeves, S; Spector, SL; Varghese, ST, 2005) |
| "Fexofenadine 180 mg is a new antihistamine that is effective in the treatment of chronic urticaria and that has a profile of side effects similar to placebo." | 2.70 | [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients]. ( Bircher, A; Degonda, M; Helbling, A; Pichler, WJ, 2002) |
| " Adverse events occurred in 20 cases (18." | 2.70 | Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria. ( Aunhachoke, K; Charuwichitratana, S; Gherunpong, N; Gritiyarangsan, P; Janjumratsang, P; Jiamton, S; Korkij, W; Krisadapong, J; Kullavanijaya, P; Kulthanan, K; Kuntiranont, M; Sitakalin, C, 2001) |
| "Treatment with hydroxyzine in patients with CU improved the clinical symptoms and modified the profile of HR; more histamine was recovered at 1 hour (p less than 0." | 2.67 | Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria. ( Bédard, PM; Brunet, C; Hébert, J, 1990) |
| "Loratadine was safe and well tolerated." | 2.67 | Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of chronic allergic skin diseases in a pediatric population. ( Cerio, R; Chieira, ML; deGroot, LJ; Giannetti, A; Gonçalves, HM; Guillot, B; Lutsky, BN; Lynde, CW; Schuller, JL; Vareltzides, A, 1993) |
| "Loratadine is a new selective peripheral histamine H1-receptor antagonist, that is orally effective, long-acting, and devoid of significant central and autonomic nervous system activity." | 2.67 | Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. ( Belaich, S; Bruttmann, G; DeGreef, H; Lachapelle, JM; Paul, E; Pedrali, P; Tennstedt, D, 1990) |
| "Total 100 patients of chronic idiopathic urticaria aged 18 years and above with exclusion and inclusion criteria were selected." | 1.56 | Efficacy of Fexofenadine in the Treatment of Chronic Idiopathic Urticaria. ( Akhter, F; Jahan, H; Nandi, AK, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (30.61) | 18.7374 |
| 1990's | 14 (28.57) | 18.2507 |
| 2000's | 15 (30.61) | 29.6817 |
| 2010's | 3 (6.12) | 24.3611 |
| 2020's | 2 (4.08) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, A | 1 |
| Sakamoto, K | 1 |
| Hagiwara-Nagasawa, M | 1 |
| Kambayashi, R | 1 |
| Chiba, K | 1 |
| Nunoi, Y | 1 |
| Izumi-Nakaseko, H | 1 |
| Matsumoto, A | 1 |
| Sugiyama, A | 1 |
| Jahan, H | 1 |
| Akhter, F | 1 |
| Nandi, AK | 1 |
| Tanizaki, H | 2 |
| Nakahigashi, K | 1 |
| Miyachi, Y | 2 |
| Kabashima, K | 2 |
| Koh, SJ | 1 |
| Kim, JW | 1 |
| Kim, BG | 1 |
| Lee, KL | 1 |
| Chun, J | 1 |
| Kim, JS | 1 |
| Yamamoto, Y | 1 |
| Nakamizo, S | 1 |
| Otsuka, A | 1 |
| Chowdhury, BA | 1 |
| Cassano, N | 1 |
| Filotico, R | 1 |
| D'Argento, V | 1 |
| Filieri, M | 1 |
| Coviello, C | 1 |
| Vena, G | 1 |
| Kawashima, M | 1 |
| Harada, S | 1 |
| Tango, T | 1 |
| Lennox, RD | 2 |
| Leahy, MJ | 2 |
| Shikiar, R | 2 |
| Harding, G | 2 |
| Leahy, M | 1 |
| Kaplan, AP | 2 |
| Spector, SL | 3 |
| Meeves, S | 2 |
| Liao, Y | 1 |
| Varghese, ST | 1 |
| Georges, G | 1 |
| Yamashita, H | 1 |
| Makino, T | 1 |
| Mizukami, H | 1 |
| Nose, M | 1 |
| Neumann, Y | 1 |
| Wood-Baker, R | 1 |
| Smith, R | 1 |
| Holgate, ST | 1 |
| Androsov, VN | 1 |
| Belostotskaia, OI | 1 |
| Il'ina, NI | 1 |
| Lutsky, BN | 1 |
| Schuller, JL | 1 |
| Cerio, R | 1 |
| Chieira, ML | 1 |
| Giannetti, A | 1 |
| Gonçalves, HM | 1 |
| deGroot, LJ | 1 |
| Vareltzides, A | 1 |
| Guillot, B | 1 |
| Lynde, CW | 1 |
| Lambert, D | 1 |
| Hantzperg, M | 1 |
| Danglas, P | 1 |
| Bloom, M | 1 |
| Andri, L | 1 |
| Senna, GE | 1 |
| Betteli, C | 1 |
| Givanni, S | 1 |
| Andri, G | 1 |
| Lombardi, C | 1 |
| Mezzelani, P | 1 |
| Kalis, B | 1 |
| Finn, AF | 2 |
| Fretwell, R | 1 |
| Qu, R | 1 |
| Long, J | 1 |
| Simpson, K | 1 |
| Jarvis, B | 1 |
| Nelson, HS | 1 |
| Reynolds, R | 1 |
| Mason, J | 1 |
| Thompson, AK | 1 |
| Schoenwetter, WF | 2 |
| Nettis, E | 1 |
| Dambra, P | 1 |
| D'Oronzio, L | 1 |
| Loria, MP | 1 |
| Ferrannini, A | 1 |
| Tursi, A | 1 |
| Amichai, B | 1 |
| Grunwald, MH | 1 |
| Brenner, L | 1 |
| Kulthanan, K | 1 |
| Gritiyarangsan, P | 1 |
| Sitakalin, C | 1 |
| Charuwichitratana, S | 1 |
| Korkij, W | 1 |
| Aunhachoke, K | 1 |
| Janjumratsang, P | 1 |
| Jiamton, S | 1 |
| Kuntiranont, M | 1 |
| Krisadapong, J | 1 |
| Gherunpong, N | 1 |
| Kullavanijaya, P | 1 |
| Degonda, M | 1 |
| Pichler, WJ | 1 |
| Bircher, A | 1 |
| Helbling, A | 1 |
| Abu Shareeah, AM | 1 |
| Ciprandi, G | 1 |
| Tosca, MA | 1 |
| Iudice, A | 1 |
| Buscaglia, S | 1 |
| Fasce, L | 1 |
| Canonica, GW | 1 |
| Ruffin, RE | 1 |
| Latimer, KM | 1 |
| Brunet, C | 1 |
| Bédard, PM | 1 |
| Hébert, J | 1 |
| Belaich, S | 1 |
| Bruttmann, G | 1 |
| DeGreef, H | 1 |
| Lachapelle, JM | 1 |
| Paul, E | 5 |
| Pedrali, P | 1 |
| Tennstedt, D | 1 |
| Kietzmann, H | 1 |
| Macher, E | 1 |
| Rihoux, JP | 1 |
| Ghys, L | 1 |
| Bödeker, RH | 3 |
| van Joost, T | 1 |
| Blog, FB | 1 |
| Westerhof, W | 1 |
| Jansen, FC | 1 |
| Starink, TM | 1 |
| den Boer, MS | 1 |
| Kuneman, JJ | 1 |
| Harvey, SG | 1 |
| Gibson, JR | 1 |
| Reinel, D | 1 |
| Ulrich, R | 1 |
| Köhler, ME | 1 |
| Boggs, PB | 1 |
| Ellis, CN | 1 |
| Grossman, J | 1 |
| Washburne, WF | 1 |
| Gupta, AK | 1 |
| Ball, R | 1 |
| Shulan, D | 1 |
| Cainelli, T | 1 |
| Seidenari, S | 1 |
| Valsecchi, R | 1 |
| Mosca, M | 1 |
| Salisbury, J | 1 |
| Bor, S | 1 |
| Blair, C | 1 |
| Shuster, S | 1 |
| Hjorth, N | 1 |
| Grant, JA | 1 |
| Bernstein, DI | 1 |
| Buckley, CE | 1 |
| Chu, T | 1 |
| Fox, RW | 1 |
| Rocklin, RE | 1 |
| Stafford, CT | 1 |
| Stroh, JE | 1 |
| Lembo, G | 1 |
| Raulo, U | 1 |
| Cantelli, V | 1 |
| Patruno, C | 1 |
| Ferguson, J | 1 |
| MacDonald, KJ | 1 |
| Kenicer, KJ | 1 |
2 reviews available for terfenadine and Chronic Disease
| Article | Year |
|---|---|
Review of fexofenadine in the treatment of chronic idiopathic urticaria.
Topics: Anti-Allergic Agents; Asia; Chronic Disease; Humans; North America; Terfenadine; Urticaria | 2002 |
Fexofenadine hydrochloride--a new anti-histaminic drug.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Interactions; Histamine H1 Antagonists; Humans; Pati | 2001 |
35 trials available for terfenadine and Chronic Disease
| Article | Year |
|---|---|
Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations.
Topics: Adult; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Histamine; Histamine H1 Ant | 2013 |
Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
Topics: Adult; Anti-Allergic Agents; Chronic Disease; Cross-Over Studies; Dibenzoxepins; Female; Histamine H | 2015 |
Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
Topics: Chronic Disease; Dermatology; Dose-Response Relationship, Drug; Double-Blind Method; Histamine H1 An | 2004 |
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Child; Chronic Disease; Double-Blind Method; Female; Humans; Male; Terfenadine; Urticari | 2005 |
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria.
Topics: Adolescent; Chronic Disease; Double-Blind Method; Efficiency; Female; Histamine H1 Antagonists, Non- | 2007 |
[Antihistaminic therapy of chronic urticaria. Results of a multicenter study with azatadine and terfenadine].
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Cyproheptadine; Female; Hist | 1984 |
A double-blind, placebo controlled study of the effect of the specific histamine H1-receptor antagonist, terfenadine, in chronic severe asthma.
Topics: Adult; Analysis of Variance; Asthma; Chronic Disease; Cross-Over Studies; Double-Blind Method; Femal | 1995 |
[The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis].
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Mid | 1994 |
Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of chronic allergic skin diseases in a pediatric population.
Topics: Child; Chronic Disease; Dermatitis, Contact; Humans; Loratadine; Skin; Solutions; Suspensions; Terfe | 1993 |
[Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria].
Topics: Adolescent; Adult; Cetirizine; Child; Chronic Disease; Double-Blind Method; Female; Humans; Male; Mi | 1993 |
A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Double-Blind Method; Humans; Terfenadine; Urticaria | 1993 |
Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
Topics: Adult; Anti-Allergic Agents; Butyrophenones; Chronic Disease; Double-Blind Method; Histamine H1 Anta | 1996 |
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonis | 1999 |
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Chronic Disease; Disorders of Excessive Somnol | 2000 |
Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Male; Middle Age | 2000 |
Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.
Topics: Acetates; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Ant | 2001 |
Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Histamine H1 Antagonists; Human | 2001 |
[Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
Topics: Adult; Aged; Anti-Allergic Agents; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middl | 2002 |
Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Adult; Chronic Disease; Cyproheptadine; Female; Histamine Antagonists; Humans; Loratadine; Male; Pru | 1992 |
Lack of effect of 4 weeks of oral H1 antagonist on bronchial responsiveness.
Topics: Administration, Oral; Adult; Asthma; Bronchoconstriction; Chronic Disease; Double-Blind Method; Drug | 1991 |
Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria.
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists; | 1990 |
Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Cyprohepta | 1990 |
Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Benzhydryl Compounds; Cetirizine; Chronic Disease; Double-Blind Method; Histamine H1 Antagonists; Hu | 1990 |
Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Clinical Trials as Topic; Double- | 1989 |
A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; | 1989 |
Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria.
Topics: Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Histamine | 1989 |
Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily.
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Fem | 1989 |
Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Histamine H1 Antagoni | 1989 |
[Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Clinical Trials as Topic; Double- | 1985 |
Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients.
Topics: Adult; Aged; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; | 1986 |
Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria.
Topics: Adolescent; Adult; Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Double-Blind M | 1986 |
A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Double-Bli | 1987 |
Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clemastine; Dermatitis, Atopic; Doub | 1988 |
Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Benzhydryl Compounds; Chlorpheniramine; Chronic Disease; Clinical Trials as Topic | 1988 |
Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study.
Topics: Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; F | 1985 |
12 other studies available for terfenadine and Chronic Disease
| Article | Year |
|---|---|
Utilization of the chronic atrioventricular block cynomolgus monkey as an in vivo model to evaluate drug interaction-associated torsade de pointes.
Topics: Animals; Atrioventricular Block; Chronic Disease; Disease Models, Animal; Drug Synergism; Ketoconazo | 2020 |
Efficacy of Fexofenadine in the Treatment of Chronic Idiopathic Urticaria.
Topics: Adolescent; Bangladesh; Chronic Disease; Chronic Urticaria; Double-Blind Method; Humans; Terfenadine | 2020 |
Fexofenadine regulates nuclear factor-κB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates acute and chronic colitis in mice.
Topics: Acute Disease; Animals; Chronic Disease; Colitis; Endoplasmic Reticulum Stress; Female; HCT116 Cells | 2015 |
Chronic urticaria and angioedema.
Topics: Angioedema; Chronic Disease; Histamine H1 Antagonists; Humans; Terfenadine; Urticaria | 2002 |
In vivo anti-inflammatory effects of fexofenadine in chronic idiopathic urticaria.
Topics: Adolescent; Adult; Biopsy, Needle; Case-Control Studies; Chronic Disease; Culture Techniques; E-Sele | 2002 |
Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Clinical Trials, Phase III as Topic; Data Interpret | 2005 |
Pharmacological characterization of a chronic pruritus model induced by multiple application of 2,4,6-trinitrochlorobenzene in NC mice.
Topics: Animals; Antipruritics; Cell Degranulation; Chronic Disease; Cromolyn Sodium; Cyproheptadine; Dermat | 2007 |
Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
Topics: Cetirizine; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Histamine Antagonists; Human | 1999 |
Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Topics: Administration, Oral; Adolescent; Adult; Anti-Allergic Agents; Chronic Disease; Dose-Response Relati | 2000 |
Terfenadine in allergic chronic cough in children.
Topics: Asthma; Child; Chronic Disease; Cough; Female; Humans; Hypersensitivity; Male; Pilot Projects; Terfe | 1992 |
Antihistamines in the treatment of urticarial disorders.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Histamine H1 Antagonists; Humans; | 1988 |
[Dermatographic urticaria: evaluation of the therapeutic efficacy of drugs using a dermatographic tester].
Topics: Adolescent; Adult; Benzhydryl Compounds; Chronic Disease; Cinnarizine; Female; Humans; Hydroxyzine; | 1987 |